Made
possible by charitable contributions from
Amgen
Oncology ,
AstraZeneca
, GTx Calypso Medical Technologies
Our monthly newsletter, the HotSheet, highlights the latest in treatment strategies as well as emerging treatments. The HotSheet is distributed
free at chapter support group meetings, and is available in PDF on the Us TOO web site.
HotSheet Personal Subscriptions Now Available
If you are unable to attend chapter meetings to get the latest issue or prefer an original copy, we can deliver the newsletter right to your home or office.
Download and print a subscription order form
or order online .
January - March |
April
- June | July - September | October - Decembar
January View Newsletter
February View Newsletter
March View Newsletter
Includes:
Overall Survival Analysis of SPARC Trial
Patients Often Get Contraindicated Therapy
Us TOO’s 2008 Board
Members/Officers
Post-Prostatectomy Incontinence Treatment
Letter to the Editor
Doc Moyad’s What Works and What is Worthless Column—Statins
Read
more..
Includes:
Senate Passes Last-Minute ‘Rescue” for Doctors Facing Big Medicare Cuts
Aspirin Impairs Prostate Cancer Treatment
More FDA Action Possible for ESAs
Cancer Tool Shows Promise in Scottsdale
Hormones Delay Prostate Cancer Growth
Research Yields Clues to Cancer Recurrence
Read
more..
Includes:
Supreme Court Declines Review in the Abigail Alliance Experimental Drug Case
Editorial: Provenge Pressure Builds on FDA
Cell Genesys’ Clinical Trials to Continue
Supreme Court Sides with Washington University in Tissue Ownership Case
No Link Between Androgen and Risk for PCa
Us TOO Raises Minority Cancer Awareness
Read
more..
April View Newsletter
MAY View Newsletter
June
Includes:
Special Burning Issues
Supplement: Highlights from ASCO’s 2008 Genitourinary Cancers Symposium—San Francisco, CA, February 14-16, 2008
New Analysis Out on Cancer Drug
GTx’s Toremifene Meets Primary Endpoints
Treatment Decision-Making Not Easy
The Power of Words for Cancer Patients
April Brings a New Look to SEA Blue for National Minority Cancer Awareness Week
Genetic Variants Found to be Associated with Prostate Cancer
Read
more..
Includes:
Doctors Use “GPS for the Body” to Target Cancer Cells
Takeda, Cell Genesys Partner to Develop Prostate Cancer Vaccine
Blood Test Indicates Nodal Spread in Localized Prostate Cancer
Medicare Changes Influenced Prostate Cancer Treatment Decisions
New Information Drives Changes in Bladder Control Treatment
Outer–Course vs. Inter-Course
Geneve Bio Developing Revolutionary Curative ED Treatment
Read
more..
HotSheets by Year
